Apart from anti-proliferative activities, BET protein-targeting agents have also been reported to induce apoptosis in a number of cancer cells, including primary osteosarcoma cells49, breast cancer cells51, and many types of hematopoietic malignancies35,37,52. This evidence concerns the gene DNER and breast carcinoma.